Studies with ifosfamide in patients with malignant lymphoma.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D004341:Drug Evaluation / Q000379:methods; D004359:Drug Therapy, Combination; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage* / Q000009:adverse effects; D008223:Lymphoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D007069:Ifosfamide